Ancora Heart Announces Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy

Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure

Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair

Guided Delivery Systems Announces Senior Leaders and Company Name Change to Ancora Heart

Ancora Heart Enrolls First Patient in U.S. Early Feasibility Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Enrolls First Patient in European Multi-Center Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Announces Key Activities for Transcatheter Cardiovascular Therapeutics 2019

Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Announces Expansion of U.S. Early Feasibility Study

Ancora Heart Receives IDE Approval for CorCinch-HF Pivotal Study of the AccuCinch® Ventricular Restoration System

To Learn More

GET IN TOUCH